# Can Adropin improve insulin sensitivity in aging populations?

Canonical source: https://retacompare.com/research/can-adropin-improve-insulin-sensitivity-in-aging-populations

Peptide Longevity Q&A · 2025-12-01


    Research indicates that Adropin may enhance insulin sensitivity and reduce oxidative stress in diabetic models, suggesting its potential role in metabolic aging. In a study with diabetic rats, Adropin treatment improved glutathione levels and modulated pancreatic cell proliferation, which are critical for maintaining metabolic health.


What the research shows

The study investigated the effects of Adropin on pancreatic cell proliferation and oxidative stress in an animal model of type 1 diabetes mellitus (DM). Using normal and diabetic Wistar rats, the researchers administered Adropin at a dosage of 2.1 µg/kg/day for 10 days. They collected pancreatic tissue samples for histomorphological analysis and inflammation assays, while blood samples were taken for oxidative stress assays. The findings revealed that diabetes induction led to increased cell proliferation in both exocrine and endocrine pancreas. However, Adropin significantly reduced this proliferation in pancreatic exocrine tissue, although it did not affect the islet of Langerhans. Moreover, Adropin treatment resulted in a notable increase in glutathione reductase expression in pancreatic tissue and elevated serum total glutathione levels in diabetic rats compared to untreated diabetic controls.


Why it matters for longevity

The findings from this study highlight the potential implications of Adropin in enhancing insulin sensitivity and reducing oxidative stress, both of which are critical factors in metabolic aging. As individuals age, the risk of developing insulin resistance increases, leading to various metabolic disorders, including type 2 diabetes. By modulating pancreatic function and improving antioxidant levels, Adropin may contribute to healthier metabolic profiles in aging populations. This could help mitigate age-related conditions and promote longevity by maintaining better metabolic health. The ability of Adropin to influence oxidative stress also suggests that it could play a role in reducing the overall burden of age-related diseases, thereby enhancing healthspan.


Key findings at a glance

Adropin treatment reduced pancreatic cell proliferation in diabetic rats.

It increased glutathione reductase expression in pancreatic tissue.

Serum total glutathione levels were significantly higher in Adropin-treated diabetic rats.

Adropin did not affect cell proliferation in the islet of Langerhans.

The study utilized a model of type 1 diabetes mellitus in Wistar rats.


How Adropin works (background)

Adropin is a peptide hormone primarily involved in energy homeostasis, with additional roles in reducing hyperlipidemia and insulin resistance. It is produced in various tissues, including the liver and brain, and is thought to influence metabolic processes. The modulation of oxidative stress and inflammation by Adropin may be linked to its ability to enhance glutathione levels, a vital antioxidant in the body. By improving oxidative status and influencing cell proliferation, Adropin could help maintain pancreatic function, which is crucial for insulin regulation and overall metabolic health.


Safety, caveats, and what we don't yet know

While the study provides insights into the potential benefits of Adropin for metabolic health, it is important to note that these findings are based on preclinical research in animal models. The effects of Adropin in human populations, particularly in older adults, remain to be fully understood. Further studies are required to assess the long-term safety and efficacy of Adropin treatment in diverse populations, including those with varying degrees of metabolic dysfunction. Additionally, the specific mechanisms through which Adropin exerts its effects on insulin sensitivity and oxidative stress need to be further elucidated.


Bottom line

Adropin shows promise in enhancing insulin sensitivity and reducing oxidative stress in diabetic models, which may have implications for metabolic aging. Further research is needed to confirm these effects in human populations.


Related questions

Does Adropin influence metabolic health in older adults?

Research suggests that Adropin may play a role in improving metabolic health by enhancing insulin sensitivity and reducing oxidative stress, which are critical factors for aging populations.


What role does oxidative stress play in aging?

Oxidative stress is a significant contributor to aging, as it can lead to cellular damage and the progression of age-related diseases. Antioxidants like glutathione help mitigate these effects.


How can peptides support metabolic health?

Peptides like Adropin may support metabolic health by regulating insulin sensitivity, reducing inflammation, and enhancing antioxidant levels, which are essential for maintaining metabolic balance.


Source: PubMed · Animal Model Exp Med · published 2025-12-01.

## Sources

- PubMed · Animal Model Exp Med: https://pubmed.ncbi.nlm.nih.gov/41215702/